Featured Topics
Lead story
Other featured articles
-
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
The highly anticipated report contains clues on how Congress may come to a different view on medications like Wegovy and Zepbound.
Posted in -
As Overdose Epidemic Shifts, Higher Doses of Addiction Treatment May Benefit Patients Long Term
Patients receiving higher doses of buprenorphine were less likely to later require emergency department services or an inpatient hospital stay, researchers found.
Posted in -
It’s Worth Challenging That Troubling Medical Bill, Study Finds
Most who sought billing help got some relief, but those who may struggle most are less likely to reach out.
Posted in -
PBM Market Concentration Varies Among Payer Types
A few pharmacy benefit managers dominate each of the payer markets, and the three biggest PBMs appear to be targeting different markets.
Posted in
The Leonard D. Schaeffer Center for Health Policy & Economics, one of the nation’s premier policy centers, measurably improves value in health through evidence-based policy solutions, research excellence, and private- and public-sector engagement.
about
Our Policy Areas
From aging to drug pricing to health disparities, Schaeffer Center experts are advancing research to inform policy. Learn about the areas we work in.
Learn MoreWork & Study at USC
The Schaeffer Center develops innovators for positions in higher education, research, government and healthcare through degree programs and postgraduate opportunities.
Learn MoreEvents
-
Seminar Series – David Bradford
W. David Bradford, Ph.D., is a health economist and the George D. Busbee Chair in Public Policy in the Department of Public Administration and Policy at the University of Georgia.Date of event: -
Seminar Series – Sarah Schutz
W. David Bradford, Ph.D., is a health economist and the George D. Busbee Chair in Public Policy in the Department of Public Administration and Policy at the University of Georgia.Date of event: -
Advancing the Science of Recruitment and Retention for Alzheimer’s Disease Clinical Trials
The existing research on Alzheimer’s clinical trial recruitment effectiveness is fragmented. Join us for a conference in Los Angeles, California to explore current challenges, evidence-based strategies, and the role of policy in making trials more effective and inclusive. Experts from academia, industry, and government will share insights on progress made, gaps that remain, and successful recruitment practices.Date of event: